Since many of the systemic inflammatory conditions mentioned as risk factors for stroke can be improved by inhibition of IL-1, this suggests a key role for this pro-inflammatory cytokine in altering stroke susceptibility and severity. This evidence concerns the gene IL1A and stroke disorder.